Coeliac Study
Don’t let Coeliac disease control your life.
This study aims to evaluate the safety and effectiveness of an investigational medication in the treatment of Coeliac disease, an autoimmune condition that can cause gut issues, chronic fatigue, and other adverse reactions when gluten is ingested.
Eligibility
- 18 - 70 years
- Medically diagnosed with Coeliac disease
- Have been managing Coeliac disease symptoms with a gluten-free diet for at least 12 months
Location
VIC, NSW, QLD, and New Zealand (all)
Dry Eye Disease Study
Help investigate a potential new treatment
This study aims to test the safety and efficacy of a new eye drop solution in people with Dry Eye Disease (DED). DED can cause discomfort and vision problems due to damage to collagen in the eye. This potential new treatment is designed to repair the damaged collagen and provide better relief from DED symptoms.
Eligibility
- 18+
- Have had DED for at least 6 months. Have used or wanted to use eye drops for at least 6 months.
Location
SA
Covid-19 & Flu Studies
Covid-19 & Flu Studies
This study aims to evaluate the safety and effectiveness of a potential new combination vaccine for COVID-19 and seasonal flu. Up to 4,000 people will participate in this important research across Australia and New Zealand.
Eligibility
- Aged 65 years and older
- In general good health
- Have received your primary vaccination series against COVID-19 with or without a booster
Location
ACT, NSW, QLD, SA, VIC, WA, and New Zealand (all)
Insomnia Study
Tired of sleepless nights?
This medical study aims to evaluate the efficacy and safety of CBD TPM (Cannabidiol, Tocopheryl Phosphate Mixture) capsules in adults to reduce the severity of insomnia symptoms.
Eligibility
- 18+
- Have difficulty getting to sleep, staying asleep and/or waking up earlier in the morning than desired
- OR have been diagnosed with insomnia.
Location
VIC, NSW, QLD, and WA
Chronic Sinusitis Study
Have you been living with chronic sinusitis without nasal polyps for the last 12 weeks?
You may be eligible to participate in a study that is evaluating a possible treatment for chronic rhinosinusitis without nasal polyps (CRSsNP).
Eligibility
- 18 to 75 years of age
- Displaying symptoms of runny and stuffy nose, facial pain, and a decreased sense of smell
- Willing to participate in the trial for 33 weeks
Location
QLD, VIC, and WA
Expression of Interest
Dementia-related Agitation Study
If you are interested in a potential new treatment for agitation associated with dementia, register your interest to be kept informed when this study opens.
Eligibility
- Aged 50 - 90
- Current diagnosis of dementia
- Experiencing agitation/aggression episodes at least twice per week
- Have a caregiver or study partner who will be available to participate in the study
Location
VIC
Expression of Interest
Healthy Volunteers
Sign up to be contacted once new studies open. Healthy volunteer trials can range from virtual trials to in-house overnight stays. Every study is different, we'll always share information at the beginning of the process and you can decide to withdraw your interest at any time.
Eligibility
- 18 to 65 years of age
- Able to commit to study schedules
- No uncontrolled or serious diseases
Location
Australia (all)
Expression of Interest
Mental Health Studies
If you are interested in participating in research investigating a potential new method of mental health diagnosis, register your interest to be kept informed when this study opens.
Eligibility
- 18+
- Currently have, or believe you may have a mental health condition
Location
Australia (all)
Expression of Interest:
High Blood Pressure Studies
We are starting a new study soon for people with mild to moderate high blood pressure. Express your interest to be contacted once the study is open.
Eligibility
- 18 to 65 years of age
- Able to commit to in-patient stays (overnight stays at study location)
Location
SA and WA
Need help with clinical trial information?
Search our Evrima help Centre for answers related to information about our active studies, information about managing your Evrilink account, and general clinical trial knowledge!
Read our FAQs